J
John F. Forbes
Researcher at University of Limerick
Publications - 373
Citations - 51254
John F. Forbes is an academic researcher from University of Limerick. The author has contributed to research in topics: Breast cancer & Tamoxifen. The author has an hindex of 88, co-authored 368 publications receiving 46433 citations. Previous affiliations of John F. Forbes include University of Newcastle & University of Melbourne.
Papers
More filters
Journal ArticleDOI
Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial
Henning T. Mouridsen,Aparna Keshaviah,Alan S. Coates,Manuela Rabaglio,Monica Castiglione-Gertsch,Zhuoxin Sun,Beat Thürlimann,Louis Mauriac,John F. Forbes,Robert Paridaens,Richard D. Gelber,Marco Colleoni,Ian E. Smith,Karen N. Price,Aron Goldhirsch +14 more
TL;DR: The present safety analysis, limited to cardiovascular AEs in BIG 1-98, documents a low overall incidence of cardiovascular AE, which differed between treatment arms.
Journal ArticleDOI
Predictors of early relapse in postmenopausal women with hormone receptor-positive breast cancer in the BIG 1-98 trial
Louis Mauriac,Aparna Keshaviah,Marc Debled,Henning T. Mouridsen,John F. Forbes,Beat Thürlimann,Robert Paridaens,Alain Monnier,István Láng,Andrew M Wardley,Jean-Marie Nogaret,Richard D. Gelber,Monica Castiglione-Gertsch,Karen N. Price,Alan S. Coates,Ian E. Smith,Giuseppe Viale,Manuela Rabaglio,N Zabaznyi,Aron Goldhirsch +19 more
TL;DR: Upfront letrozole resulted in significantly fewer early relapses than tamoxifen, even after adjusting for significant prognostic factors, as well as no significant interactions between treatment and the covariates.
Journal ArticleDOI
The Cost of Stroke to the National Health Service in Scotland
Phoebe A. Isard,John F. Forbes +1 more
TL;DR: Scottish National Health Service (NHS) stroke costs have been estimated for 1988 using accounting methods, updating a similar study for 1974.
Journal ArticleDOI
Interpreting self reported limiting long term illness
TL;DR: A positive response to the question used by the census to define limiting long term illness was strongly associated with physical limitations on activity and less strongly influenced by scores on scales of mental and social wellbeing.
Journal ArticleDOI
Cost-Effectiveness of Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke Assessed by a Model Based on UK NHS Costs
Peter Sandercock,Eivind Berge,Martin Dennis,John F. Forbes,Peter J. Hand,Joseph Kwan,Steff Lewis,Richard I. Lindley,Aileen Rae Neilson,Joanna M. Wardlaw +9 more
TL;DR: The data did not support the widespread use of thrombolytic therapy outside the terms of the current restricted license in routine clinical practice in the NHS and the estimates of effectiveness and cost-effectiveness were imprecise.